As a specific lyscarbamate inhibitor and its ingredients for the treatment of schizophrenia, Alzheimer's disease, Parkinson's disease, epilepsy, etc.

• 收藏
• 分享

专利权人:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

发明人:

MATSUMOTO, Shigemitsu,HATTORI, Yasushi,TOYOFUKU, Masashi,MORIMOTO, Shinji,DAINI, Masaki,KOJIMA, Takuto,KAKU, Tomohiro,ITO, Mitsuhiro

申请号：

CL2016002573

公开号：

CL2016002573A1

申请日:

2016.10.07

申请国别(地区):

CL

年份:

2017

代理人:

摘要：

1. Compounds made from cycloarylonitrile and its salts, such as specific lysine-1 inhibitors of lysine LSD 1, drugs containing this substance and their use in the treatment of schizophrenia, Alzheimer's disease, Parkinson's disease, epilepsy, etc.Compuestos derivados de ciclopropanamina o sus sales, como inhibidores de desmetilasa-1 especifica de lisina LSD1, medicamento que los comprende y su uso para tratar esquizofrenia, enfermedad de alzheimer, enfermedad de parkinson, epilepsia, entre otras.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/